C74.12
Malignant neoplasm of medulla of left adrenal gland
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the medulla of the left adrenal gland is a serious condition characterized by the growth of cancerous cells in the medulla, the innermost part of the adrenal gland located on the left side of the body. The adrenal glands are small, triangular-shaped organs situated on top of each kidney, responsible for producing hormones that regulate essential bodily functions. When cancer develops in this region, it can affect hormone production and potentially spread to other parts of the body. This guide aims to provide an understanding of this condition, including its causes, symptoms, diagnosis, and treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations or inherited syndromes that predispose to adrenal tumors Exposure to certain chemicals or toxins Familial cancer syndromes involving endocrine tumors Unknown factors in many cases
Key Symptoms: Sudden or persistent abdominal or back pain Unexplained weight loss and fatigue High blood pressure or episodes of hypertension Hormonal imbalances causing symptoms such as excessive sweating, rapid heartbeat, or anxiety Palpitations and episodes of sweating or flushing
Diagnostic & Treatment
Diagnosis Path: Diagnosing a malignant neoplasm of the adrenal medulla typically involves several steps. Initial evaluation often includes a thorough physical examination and medical history. Imaging techniques such as computed tomography (CT) scans or magnetic resonance imaging (MRI) are used to visualize the adrenal glands and identify tumors. Blood and urine tests may be conducted to measure hormone levels and detect markers indicative of tumor activity. A biopsy, in which a small tissue sample is extracted for laboratory analysis, is usually performed to confirm malignancy. Additional tests such as MIBG scans or PET scans can help determine if the cancer has spread beyond the adrenal gland.
Treatment Protocols: Treatment strategies depend on the size, type, and spread of the tumor and include several options: - Surgical Removal: The primary treatment often involves surgically removing the tumor along with the affected adrenal gland. This approach aims to eliminate the cancer and may include procedures to remove nearby lymph nodes if necessary. - Chemotherapy: Use of anti-cancer medications to destroy cancer cells, especially if the cancer has spread beyond the adrenal gland. - Radiotherapy: Targeted radiation may be used to shrink tumors or treat residual cancer cells post-surgery. - Targeted Therapy: Newer medications designed to target specific molecules involved in tumor growth might be utilized in certain cases. - Hormonal Therapy: Since these tumors can impact hormone levels, therapies aimed at managing hormonal imbalances may be part of the treatment plan. Follow-up care is vital to monitor for potential recurrence or spread of the disease, involving regular imaging and lab tests.
Clinical Advice & FAQs
Billing Guidance
Is C74.12 a billable ICD-10 code?
Yes, C74.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C74.12?
Clinical documentation must specify the nature of Malignant neoplasm of medulla of left adrenal gland and any associated comorbidities for accurate reporting.
Cite this Clinical Reference